Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Share-based Compensation (2016 - 2026)

Anika Therapeutics has reported Share-based Compensation over the past 17 years, most recently at $6.6 million for Q1 2026.

  • Quarterly Share-based Compensation rose 131.96% to $6.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Mar 2026, down 2.72% year-over-year, with the annual reading at $10.2 million for FY2025, 22.19% down from the prior year.
  • Share-based Compensation was $6.6 million for Q1 2026 at Anika Therapeutics, up from $2.6 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $6.6 million in Q1 2026 and troughed at -$132000.0 in Q3 2025.
  • The 5-year median for Share-based Compensation is $3.4 million (2024), against an average of $3.3 million.
  • Year-over-year, Share-based Compensation plummeted 103.89% in 2025 and then skyrocketed 131.96% in 2026.
  • A 5-year view of Share-based Compensation shows it stood at $3.8 million in 2022, then grew by 0.05% to $3.8 million in 2023, then tumbled by 40.89% to $2.3 million in 2024, then increased by 14.86% to $2.6 million in 2025, then skyrocketed by 156.41% to $6.6 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Share-based Compensation are $6.6 million (Q1 2026), $2.6 million (Q4 2025), and -$132000.0 (Q3 2025).